/ENOV
ENOV Stock - Enovis Corporation
Industrials|Industrial - MachineryNYSE
$26.76-2.05%
$0.56 (-2.05%) • Dec 19
59
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.12
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.54
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+86.8%upside
Target: $49.99
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ENOV
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$26.49 – $27.03
TARGET (TP)$50.00
STOP LOSS$24.62
RISK/REWARD1:10.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.65
52W High$49.38
52W Low$25.47
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $2.11B | $1.71B | $1.56B | $1.43B | $1.12B |
| Gross Profit | $1.18B | $990.78M | $869.38M | $777.67M | $603.64M |
| Gross Margin | 56.0% | 58.0% | 55.6% | 54.5% | 53.9% |
| Operating Income | $-775,719,000 | $-65,709,000 | $-71,178,000 | $-62,799,000 | $-66,182,000 |
| Net Income | $-825,494,000 | $-33,261,000 | $-13,292,000 | $71.66M | $42.63M |
| Net Margin | -39.2% | -1.9% | -0.9% | 5.0% | 3.8% |
| EPS | $-14.93 | $-0.61 | $-0.28 | $-2.02 | $1.13 |
Company Overview
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
11
79%
Hold / Neutral
3
21%
Sell / Underperform
0%
Analyst Consensus🟢 Bullish
11 Bullish3 Neutral/Bearish
Price Targets
$66
Average Target
↑ 146.9% Upside
Now
$53
Low
$66
Average
$75
High
Based on 14 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| October 3rd 2024 | JMP Securities | Initiation | Mkt Outperform | $62 |
| June 13th 2024 | JP Morgan | Initiation | Neutral | $53 |
| February 13th 2024 | Stephens | Initiation | Overweight | $72 |
| January 22nd 2024 | UBS | Initiation | Buy | $75 |
| January 3rd 2024 | William Blair | Initiation | Outperform | - |
| December 15th 2023 | Needham | Reiterated | Buy | $70← $62 |
| October 20th 2023 | ROTH MKM | Initiation | Buy | $75 |
| June 26th 2023 | Needham | Initiation | Buy | $70 |
| May 12th 2023 | Wells Fargo | Upgrade | Overweight | $67← $55 |
| October 12th 2022 | Jefferies | Initiation | Buy | $60 |
| October 11th 2022 | Goldman | Initiation | Buy | $57 |
| September 12th 2022 | Evercore ISI | Initiation | Outperform | $68 |
| September 12th 2022 | Canaccord Genuity | Initiation | Buy | $67 |
| June 28th 2022 | Argus | Initiation | Hold | - |
| June 27th 2022 | Loop Capital | Resumed | Buy | $68 |
Earnings History & Surprises
ENOVBeat Rate
94%
Last 18 quarters
Avg Surprise
+9.2%
EPS vs Estimate
Beats / Misses
17/0
1 met exactly
Latest EPS
$0.75
Q4 2025
EPS Surprise History
Q1 24
+3.9%
$0.79vs$0.76
Q2 24
0.0%
$0.50vs$0.50
Q3 24
+3.3%
$0.62vs$0.60
Q4 24
+15.9%
$0.73vs$0.63
Q1 25
+6.5%
$0.98vs$0.92
Q2 25
+9.5%
$0.81vs$0.74
Q3 25
+6.8%
$0.79vs$0.74
Q4 25
+11.9%
$0.75vs$0.67
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 6, 2026 | — | — | — | — |
Q1 2026 | Feb 25, 2026 | $0.81 | — | — | — |
Q4 2025 | Nov 6, 2025 | $0.67 | $0.75 | +11.9% | ✓ BEAT |
Q3 2025 | Aug 7, 2025 | $0.74 | $0.79 | +6.8% | ✓ BEAT |
Q2 2025 | May 8, 2025 | $0.74 | $0.81 | +9.5% | ✓ BEAT |
Q1 2025 | Feb 26, 2025 | $0.92 | $0.98 | +6.5% | ✓ BEAT |
Q4 2024 | Nov 6, 2024 | $0.63 | $0.73 | +15.9% | ✓ BEAT |
Q3 2024 | Aug 7, 2024 | $0.60 | $0.62 | +3.3% | ✓ BEAT |
Q2 2024 | May 2, 2024 | $0.50 | $0.50 | 0.0% | = MET |
Q1 2024 | Feb 22, 2024 | $0.76 | $0.79 | +3.9% | ✓ BEAT |
Q4 2023 | Nov 7, 2023 | $0.53 | $0.56 | +5.7% | ✓ BEAT |
Q3 2023 | Aug 3, 2023 | $0.53 | $0.61 | +15.1% | ✓ BEAT |
Q2 2023 | May 4, 2023 | $0.37 | $0.44 | +18.9% | ✓ BEAT |
Q1 2023 | Feb 23, 2023 | $0.69 | $0.72 | +4.3% | ✓ BEAT |
Q4 2022 | Nov 2, 2022 | $0.47 | $0.59 | +25.5% | ✓ BEAT |
Q3 2022 | Aug 4, 2022 | $0.49 | $0.59 | +20.4% | ✓ BEAT |
Q2 2022 | May 10, 2022 | $0.34 | $0.37 | +8.8% | ✓ BEAT |
Q1 2022 | Feb 22, 2022 | $1.72 | $1.77 | +2.9% | ✓ BEAT |
Q4 2021 | Nov 4, 2021 | $1.60 | $1.62 | +1.3% | ✓ BEAT |
Q3 2021 | Jul 28, 2021 | $1.59 | $1.68 | +5.7% | ✓ BEAT |
Latest News
Canaccord Genuity Maintains Buy on Enovis, Lowers Price Target to $50
➖ NeutralBenzinga•Dec 17, 2025, 08:14 PM•Also:
Freedom Capital Markets Initiates Coverage On Enovis with Buy Rating, Announces Price Target of $45
📈 PositiveBenzinga•Dec 17, 2025, 09:19 AM
Wells Fargo Maintains Overweight on Enovis, Raises Price Target to $42
📈 PositiveBenzinga•Nov 7, 2025, 06:51 PM
Enovis Raises FY2025 Adj EPS Guidance from $3.05-$3.20 to $3.10-$3.25 vs $3.12 Est; Lowers FY2025 Sales Guidance from $2.245B-$2.275B to $2.240B-$2.270B vs $2.255B Est
➖ NeutralBenzinga•Nov 6, 2025, 11:05 AM
Enovis Q3 Adj. EPS $0.75 Beats $0.65 Estimate, Sales $548.912M Beat $538.617M Estimate
📈 PositiveBenzinga•Nov 6, 2025, 11:03 AM
Frequently Asked Questions about ENOV
What is ENOV's current stock price?
Enovis Corporation (ENOV) is currently trading at $26.76 per share. The stock has moved -2.05% today.
What is the analyst price target for ENOV?
The average analyst price target for ENOV is $50.00, based on 1 analyst.
What sector is Enovis Corporation in?
Enovis Corporation operates in the Industrials sector, specifically within the Industrial - Machinery industry. The company is traded on the NYSE exchange.
What is ENOV's market cap?
Enovis Corporation has a market capitalization of $1.53 billion, making it a small-cap company.
Does ENOV pay dividends?
No, Enovis Corporation does not currently pay a dividend to shareholders.
Similar Stocks
Industrials SectorDCI
Donaldson Company, Inc.
$92.61
Mkt Cap: $10.7B
EPAC
Enerpac Tool Group Corp.
$37.23
Mkt Cap: $2.0B
FELE
Franklin Electric Co., Inc.
$97.32
Mkt Cap: $4.3B
GHM
Graham Corporation
$61.57
Mkt Cap: $0.7B
GRC
The Gorman-Rupp Company
$49.10
Mkt Cap: $1.3B
HLIO
Helios Technologies, Inc.
$54.66
Mkt Cap: $1.8B
HURC
Hurco Companies, Inc.
$14.88
Mkt Cap: $0.1B
IEX
IDEX Corporation
$177.78
Mkt Cap: $13.4B
ITT
ITT Inc.
$176.50
Mkt Cap: $13.8B
KAI
Kadant Inc.
$288.94
Mkt Cap: $3.4B
Explore stocks similar to ENOV for comparison